Stock Analiz

MapLight Therapeutics, Inc. (MPLT) stock forecast and price target

Price $7.25 · data as of November 13, 2026

12-month price target

Average target$26.54
Upside / downside+266.0%
Analysts13
ConsensusNone
Low $13.00Average $26.54High $43.00

Gold marker: average target · white marker: today’s price ($7.25)

Analyst ratings

Strong buy 1Buy 11Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-4.49+75.8%$0
Next fiscal year
ends December 31, 2027
$-3.42+23.9%$15M
Quarter after
ends December 31, 2026
$-1.04+57.8%$0

Consensus of the analysts covering MapLight Therapeutics, updated daily. In the last 30 days 5 estimates were raised and 0 lowered.

Frequently asked questions

What is the MapLight Therapeutics stock price target?

The average 12-month target from 13 analysts is $26.54, 266.0% above the current price of $7.25 Targets range from $13.00 to $43.00.

Is MapLight Therapeutics a buy according to analysts?

The consensus rating is “None” (1 strong buy, 11 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is MapLight Therapeutics expected to earn?

Analysts expect EPS of $-4.49 for the fiscal year ending December 31, 2026 and $-3.42 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.